References
- MehannaMMMohyeldinSMElgindyNARespirable nanocarriers as a promising strategy for antitubercular drug deliveryJ Control Release201418718319724878180
- CamineroJASotgiuGZumlaAMiglioriGBBest drug treatment for multidrug-resistant and extensively drug-resistant tuberculosisLancet Infect Dis20101062162920797644
- PandeyRAhmadZNanomedicine and experimental tuberculosis: facts, flaws, and futureNanomedicine2011725927221329765
- GumboTLouieADezielMRConcentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampinAntimicrob Agents Chemother2007513781378817724157
- BeckerCDressmanJBJungingerHEBiowaiver monographs for immediate release solid oral dosage forms: rifampicinJ Pharm Sci2009982252226719160441
- MariappanTSinghSPositioning of rifampicin in the biopharmaceutics classification system (BCS)Clin Res Regul Aff200623110
- BurmanWJGallicanoKPeloquinCComparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterialsClin Pharmacokinet20014032734111432536
- SaraogiGKGuptaPGuptaUDJainNKAgrawalGPGelatin nanocarriers as potential vectors for effective management of tuberculosisInt J Pharm201038514314919819315
- BooysenLLKalomboLBrooksEIn vivo/in vitro pharmacokinetic and pharmacodynamic study of spray-dried poly-(dl-lactic-co-glycolic) acid nanoparticles encapsulating rifampicin and isoniazidInt J Pharm2013444101723357255
- TewesFBrillaultJCouetWOlivierJCFormulation of rifampicin–cyclodextrin complexes for lung nebulizationJ Control Release2008129939918514353
- SonYJMcConvilleJTA new respirable form of rifampicinEur J Pharm Biopharm20117836637621324356
- RabinowBENanosuspensions in drug deliveryNat Rev Drug Discov2004378579615340388
- KesisoglouFPanmaiSWuYNanosizing – oral formulation development and biopharmaceutical evaluationAdv Drug Deliv Rev20075963164417601629
- TianXLiHZhangDNanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studiesColloids Surf B Biointerfaces2013108293323528604
- FreagMSElnaggarYSAbdallahOYDevelopment of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeationInt J Pharm201345446247123830765
- DasSSureshPKNanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin BNanomedicine2011724224720692375
- SaindaneNSPagarKPVaviaPRNanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterizationAAPS PharmSciTech20131418919923255198
- SinhaBMüllerRHMöschwitzerJPBottom-up approaches for preparing drug nanocrystals: formulations and factors affecting particle sizeInt J Pharm201345312614123333709
- XiaDQuanPPiaoHPreparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailabilityEur J Pharm Sci20104032533420417274
- KakranMSahooNGLiLJudehMAFabrication of quercetin nanoparticles by anti-solvent precipitation method for enhanced dissolutionPowder Technol20122235964
- HaoLWangXZhangDStudies on the preparation, characterization and pharmacokinetics of Amoitone B nanocrystalsInt J Pharm201243315716422579996
- ZhangHHollisCPZhangQLiTPreparation and antitumor study of camptothecin nanocrystalsInt J Pharm201141529330021679755
- HiguchiJConnorsKPhase solubility techniquesAdv Anal Chem Instrum19654117212
- AmbrusRKocbekPKristlJSibancRRajkóRSzabó-RévészPInvestigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicamInt J Pharm200938115315919616609
- LiuDXuHTianBFabrication of carvedilol nanosuspensions through the anti-solvent precipitation–ultrasonication method for the improvement of dissolution rate and oral bioavailabilityAAPS PharmSciTech20121329530422246736
- GaoYLiZSunMPreparation and characterization of intravenously injectable curcumin nanosuspensionDrug Deliv20111813114220939679
- VermaSGokhaleRBurgessDJA comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensionsInt J Pharm200938021622219596059
- DongYNgWKShenSKimSTanRBPreparation and characterization of spironolactone nanoparticles by antisolvent precipitationInt J Pharm2009375848819481693
- KoradiaDKParikhHRDissolution enhancement of albendazole through nanocrystal formulationJ Pharm Bioallied Sci20124S62S6323066210
- UngaroFd’AngeloIColettaCDry powders based on PLGA nanoparticles for pulmonary delivery of antibiotics: modulation of encapsulation efficiency, release rate and lung deposition pattern by hydrophilic polymersJ Control Release201215714915921864595
- MatteucciMEHotzeMAJohnstonKPDrug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilizationLangmuir2006228951895917014140
- ThoratAADalviSVLiquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: recent developments and future perspectiveChem Eng J2012181182134
- HuJNgWKDongYShenSTanRBContinuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-dryingInt J Pharm201140419820421056643
- WangYZhengYZhangLWangQZhangDStability of nanosuspensions in drug deliveryJ Control Release20131721126114123954372
- VermaSKumarSGokhaleRBurgessDJPhysical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripeningInt J Pharm201140614515221185926
- AliHSYorkPAliAMBlagdenNHydrocortisone nanosuspensions for ophthalmic delivery: a comparative study between microfluidic nanoprecipitation and wet millingJ Control Release201114917518120946923
- SepassiSGoodwinDJDrakeAFEffect of polymer molecular weight on the production of drug nanoparticlesJ Pharm Sci2007962655266617696165
- MorakulBSuksiriworapongJLeanpolchareanchaiJJunyaprasertVBPrecipitation-lyophilization-homogenization (PLH) for preparation of clarithromycin nanocrystals: influencing factors on physicochemical properties and stabilityInt J Pharm201345718719624076396
- GhoshIBoseSVippaguntaRHarmonFNanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growthInt J Pharm201140926026821371540
- VermaSHueyBDBurgessDJScanning probe microscopy method for nanosuspension stabilizer selectionLangmuir200925124811248719791747
- ChoiJ-YYooJYKwakH-SLeeJRole of polymeric stabilizers for drug nanocrystal dispersionsCurr Appl Phys20055472474
- Luque de CastroMDPriego-CapoteFUltrasound-assisted crystallization (sonocrystallization)Ultrason Sonochem20071471772417254828
- KakranMSahooNGTanI-LLiLPreparation of nanoparticles of poorly water-soluble antioxidant curcumin by antisolvent precipitation methodsJ Nanopart Res20121411122448125
- GuoJ-jYueP-FLvJ-lDevelopment and in vivo/in vitro evaluation of novel herpetrione nanosuspensionInt J Pharm201344122723323220096
- ZuYSunWZhaoXPreparation and characterization of amorphous amphotericin B nanoparticles for oral administration through liquid antisolvent precipitationEur J Pharm Sci20145310911724345795
- ZhangXXiaQGuNPreparation of all-trans retinoic acid nanosuspensions using a modified precipitation methodDrug Dev Ind Pharm20063285786316908423
- DressmanJBAmidonGLReppasCShahVPDissolution testing as a prognostic tool for oral drug absorption: immediate release dosage formsPharm Res19981511229487541
- AgrawalSAshokrajYBharatamPVPillaiOPanchagnulaRSolid-state characterization of rifampicin samples and its biopharmaceutic relevanceEur J Pharm Sci20042212714415158898
- HongCDangYLinGEffects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluationInt J Pharm201447725126025445518
- LefortRDe GussemeAWillartJFDanèdeFDescampsMSolid state NMR and DSC methods for quantifying the amorphous content in solid dosage forms: an application to ball-milling of trehaloseInt J Pharm200428020921915265560
- DongSHiraniIAAColacinoKRLeeYLRomanMCytotoxicity and cellular uptake of cellulose nanocrystalsNano LIFE2012021241006
- MahmoudKAMenaJAMaleKBHrapovicSKamenALuongJHEffect of surface charge on the cellular uptake and cytotoxicity of fluorescent labeled cellulose nanocrystalsACS Appl Mater Interfaces201022924293220919683